Decreased secretion of melatonin was reported to be associated with an enhanced risk of hypertension and diabetes. However, the effect of melatonin on gestational hypertension (GH) and the underlying mechanism remain unclear. A GH mouse model was established via electrical stimulation. The hypertensive phenotypes were indicated by systolic blood pressure (SBP) and urinary protein levels. Uterine artery (UtA) endothelial function was detected by relaxation, peak systolic velocity (PSV), end-diastolic velocity (EDV), resistance index (RI) and pulsatility index (PI). Protein expression levels were determined using immunochemistry and Western blots. Pregnancy outcomes were indicated by the fetal live ratio, fetal weight and placental weight. Melatonin supplementation ameliorated hypertensive phenotypes in the mice with GH and enhanced UtA endothelial response to acetylcholine. The BKCa potassium channel was involved in the effect of melatonin on UtA endothelial function, and melatonin promoted BKCa potassium channel expression and function in UtAs. Finally, melatonin improved pregnancy outcomes in pregnant mice. In conclusion, melatonin ameliorates hypertension in hypertensive pregnant mice and suppresses hypertension-induced decreases in Ca2+-activated K+ channels in uterine arteries.
Subscribe to Journal
Get full journal access for 1 year
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Wang Z, Bao X, Song L, Tian Y, Sun P. Role of miR-106-mediated mitogen-activated protein kinase signaling pathway in oxidative stress injury and inflammatory infiltration in the liver of the mouse with gestational hypertension. J Cell Biochem. 2019. https://doi.org/10.1002/jcb.29552.
Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36:56–59.
Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A brief overview of preeclampsia. J Clin Med Res. 2014;6:1–7.
Weinberger MH. Journal of the American Society of Hypertension. From the editor. J Am Soc Hypertens. 2013;7:105–6.
Dai L, Chen Y, Sun W, Liu S. Association between hypertensive disorders during pregnancy and the subsequent risk of end-stage renal disease: a population-based follow-up study. J Obstet Gynaecol Can. 2018;40:1129–38.
Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
Vangrieken P, Remels AHV, Al-Nasiry S, Bast A, Janssen GMJ, von Rango U, et al. Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity. Hypertens Res. 2020;43:1361–74.
Salmani D, Purushothaman S, Somashekara SC, Gnanagurudasan E, Sumangaladevi K, Harikishan R, et al. Study of structural changes in placenta in pregnancy-induced hypertension. J Nat Sci Biol Med. 2014;5:352–5.
Luo JY, Fu D, Wu YQ, Gao Y. Inhibition of the JAK2/STAT3/SOSC1 signaling pathway improves secretion function of vascular endothelial cells in a rat model of pregnancy-induced hypertension. Cell Physiol Biochem. 2016;40:527–37.
Chen X, Qi L, Fan X, Tao H, Zhang M, Gao Q, et al. Prenatal hypoxia affected endothelium-dependent vasodilation in mesenteric arteries of aged offspring via increased oxidative stress. Hypertens Res. 2019;42:863–75.
Ren Y, Wang H, Qin H, Yang J, Wang Y, Jiang S, et al. Vascular Endothelial Growth Factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance. Pak J Med Sci. 2014;30:634–7.
Claustrat B, Leston J. Melatonin: physiological effects in humans. Neurochirurgie. 2015;61:77–84.
Ohashi N, Ishigaki S, Isobe S. The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin-angiotensin system in the kidney. Hypertens Res. 2019;42:761–8.
Rahman A, Hasan AU, Kobori H. Melatonin in chronic kidney disease: a promising chronotherapy targeting the intrarenal renin-angiotensin system. Hypertens Res. 2019;42:920–3.
Nishi EE, Almeida VR, Amaral FG, Simon KA, Futuro-Neto HA, Pontes RB, et al. Melatonin attenuates renal sympathetic overactivity and reactive oxygen species in the brain in neurogenic hypertension. Hypertens Res. 2019;42:1683–91.
Ishigaki S, Ohashi N, Matsuyama T, Isobe S, Tsuji N, Iwakura T, et al. Melatonin ameliorates intrarenal renin-angiotensin system in a 5/6 nephrectomy rat model. Clin Exp Nephrol. 2018;22:539–49.
Nagasawa Y, Hasuike Y, Kuragano T, Ishihara M. Circadian rhythm and CKD: is melatonin a key player or bi-player? Intern Med. 2019;58:1531–2.
Ohashi N, Ishigaki S, Isobe S, Matsuyama T, Sato T, Fujikura T, et al. Salt loading aggravates the relationship between melatonin and proteinuria in patients with chronic kidney disease. Intern Med. 2019;58:1557–64.
Soliman A, Lacasse AA, Lanoix D, Sagrillo-Fagundes L, Boulard V, Vaillancourt C. Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation. J Pineal Res. 2015;59:38–46.
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–44.
Shimada M, Seki H, Samejima M, Hayase M, Shirai F. Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: a prospective analysis. Biosci Trends. 2016;10:34–41.
Tain YL, Chen CC, Sheen JM, Yu HR, Tiao MM, Kuo HC, et al. Melatonin attenuates prenatal dexamethasone-induced blood pressure increase in a rat model. J Am Soc Hypertens. 2014;8:216–26.
Zuo J, Jiang Z. Melatonin attenuates hypertension and oxidative stress in a rat model of L-NAME-induced gestational hypertension. Vasc Med. 2020;25:295–301.
Nair AR, Silva SD Jr., Agbor LN, Wu J, Nakagawa P, Mukohda M, et al. Endothelial PPARγ (peroxisome proliferator-activated receptor-γ) protects from angiotensin ii-induced endothelial dysfunction in adult offspring born from pregnancies complicated by hypertension. Hypertension. 2019;74:173–83.
Hanswijk SI, Spoelder M, Shan L, Verheij MMM, Muilwijk OG, Li W, et al. Gestational factors throughout fetal neurodevelopment: the serotonin link. Int J Mol Sci. 2020;21:5850.
Medarov BI, Judson MA. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today? Respir Med. 2015;109:557–64.
Sica DA. Pharmacotherapy review: calcium channel blockers. J Clin Hypertens. 2006;8:53–56.
Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens. 2010;28:446–51.
Gubin DG, Gubin GD, Gapon LI, Weinert D. Daily melatonin administration attenuates age-dependent disturbances of cardiovascular rhythms. Curr Aging Sci. 2016;9:5–13.
Simko F, Reiter RJ, Paulis L. Melatonin as a rational alternative in the conservative treatment of resistant hypertension. Hypertens Res. 2019;42:1828–31.
Jackson WF. Potassium channels in regulation of vascular smooth muscle contraction and growth. Adv Pharm. 2017;78:89–144.
Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol. 2001;21:28–38.
Finol-Urdaneta RK, Remedi MS, Raasch W, Becker S, Clark RB, Strüver N, et al. Block of Kv1.7 potassium currents increases glucose-stimulated insulin secretion. EMBO Mol Med. 2012;4:424–34.
Choi BH, Hahn SJ. Kv1.3: a potential pharmacological target for diabetes. Acta Pharm Sin. 2010;31:1031–5.
Djokic V, Jankovic S, Labudovic-Borovic M, Rakocevic J, Stanisic J, Rajkovic J, et al. Pregnancy-induced hypertension decreases K(v)1.3 potassium channel expression and function in human umbilical vein smooth muscle. Eur J Pharm. 2020;882:173281.
Hill MA, Yang Y, Ella SR, Davis MJ, Braun AP. Large conductance, Ca2+-activated K+ channels (BKCa) and arteriolar myogenic signaling. FEBS Lett. 2010;584:2033–42.
Hu XQ, Xiao D, Zhu R, Huang X, Yang S, Wilson SM, et al. Chronic hypoxia suppresses pregnancy-induced upregulation of large-conductance Ca2+-activated K+ channel activity in uterine arteries. Hypertension. 2012;60:214–22.
Hu XQ, Xiao D, Zhu R, Huang X, Yang S, Wilson S, et al. Pregnancy upregulates large-conductance Ca(2+)-activated K(+) channel activity and attenuates myogenic tone in uterine arteries. Hypertension. 2011;58:1132–9.
Xu Z, Wu Y, Zhang Y, Zhang H, Shi L. Melatonin activates BK(Ca) channels in cerebral artery myocytes via both direct and MT receptor/PKC-mediated pathway. Eur J Pharm. 2019;842:177–88.
Zhao T, Zhang H, Jin C, Qiu F, Wu Y, Shi L. Melatonin mediates vasodilation through both direct and indirect activation of BK(Ca) channels. J Mol Endocrinol. 2017;59:219–33.
Al Dera H, Alassiri M, Eleawa SM, AlKhateeb MA, Hussein AM, Dallak M, et al. Melatonin improves memory deficits in rats with cerebral hypoperfusion, possibly, through decreasing the expression of small-conductance Ca(2+)-activated K(+) channels. Neurochem Res. 2019;44:1851–68.
Conflict of interest
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sun, Y., Wang, C., Zhang, N. et al. Melatonin ameliorates hypertension in hypertensive pregnant mice and suppresses the hypertension-induced decrease in Ca2+-activated K+ channels in uterine arteries. Hypertens Res (2021). https://doi.org/10.1038/s41440-021-00675-5
- K+ channel
- Uterine arteries